Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells

Nadire Duru1, Ramkishore Gernapudi1, Gabriel Eades1

  • 1Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201.

Insights

Chemopreventive strategies targeting microRNAs (miRNAs) show promise for breast cancer. These agents can epigenetically activate tumor-suppressing miRNAs, inhibiting ductal carcinoma in situ stem cells and preventing invasive progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial regulators in cancer development and progression.
  • Dysregulation of miRNAs is observed early in breast cancer, even in non-malignant stages like Ductal Carcinoma In Situ (DCIS).
  • Dietary chemopreventive agents offer potential therapeutic strategies by modulating miRNA expression.

Purpose of the Study:

  • To investigate the role of miRNAs in early breast cancer, specifically DCIS.
  • To explore how chemopreventive agents impact miRNA signaling pathways.
  • To determine if chemopreventive agents can target DCIS stem cells via miRNA activation.

Main Methods:

  • Analysis of miRNA dysregulation in early breast cancer.
  • Investigating the epigenetic activation of miRNA pathways by chemopreventive agents.
  • Assessing the effect of chemopreventive agents on DCIS stem cells and tumor formation in vivo.

Main Results:

  • miRNAs are dysregulated at the earliest stages of breast cancer (DCIS).
  • Chemopreventive agents can epigenetically activate miRNA signaling pathways.
  • Activated miRNAs target cancer stem cell signaling, inhibiting DCIS stem cells and blocking tumor formation.
  • miRNAs play a role in regulating DCIS stem cells, influencing progression to invasive disease.

Conclusions:

  • MicroRNAs are critical early targets for breast cancer chemoprevention.
  • Dietary agents can activate tumor suppressor miRNAs, offering a novel strategy against DCIS.
  • Targeting DCIS stem cells through miRNA activation presents a promising approach to prevent invasive breast cancer progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.8K
MicroRNAs01:22

MicroRNAs

12.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.4K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K